- ANALYSIS: Sugaring the pill when mass layoffs are inevitable
- Royalty's shareholder lure turns screws on Elan
- Results Preview: Can BMS pull itself up from the trough?
- Stockwatch: as pharma becomes the new biotech
ONLY 0 DAY LEFT
|Stay close to your market. Renew online now to ensure uninterrupted access to:|
|SCRIP Intelligence's news and expert commentary|
|Market Data and Company Analysis (SCRIP 100, SCRIP Asia 100)|
|The Ask the Analyst Service...and more.|
Please remember to quote your order number and customer number.
You can also renew by calling: +44 (0)20 7017 5540.